Rocket Fuel
Advanced Search
Print    Email
Decrease (-) Restore Default Increase (+)
Find a Physician

Head and Neck Cancer Clinical Trial

Please check with your doctor or call 1-855-HCH-HOPE to find out if you qualify for any of these studies.

Trial  #

Trial Sub-type

Title

RTOG 1216
NCI

Histologically proven diagnosis of squamous cell carcinoma (HNSCC) involving the oral cavity, oropharynx (p16 negative), larynx, or hypopharynx within 49 days of registration ;stage III or IV

Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck. 

     Icon-LinkedIn.png 

© 2014  Holy Cross Health | 1500 Forest Glen Road, Silver Spring, MD 20910 | 301-754-7000
trinity-health.org